SRTS...rocketeer, A buyout is always possible, just hope if/when it happens, it's not too soon. Too much growth in SRTS's keloid treatments in China (worldwide?) and Scuptura (IORT). And of coarse their skin cancer treatments. Also, FWIW, Sensus was talking about possibly making a acquisition last year, but nothing is/was etched in stone.
News 
Market Data 
Discover 
AI
